2071 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Zelenetz
    Zelenetz
  4. Yahalom
    Yahalom
  5. Cheung
    Cheung
  6. O'Reilly
    O'Reilly
  7. Kushner
    Kushner
  8. Perales
    Perales
  9. La Quaglia
    La Quaglia
  10. Giralt
    Giralt

Groups

  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)
  7. Surgery (287)
  8. GSK Faculty (276)
  9. Breast Medicine Service (255)
  10. Tow Center for Developmental Oncology (TCDO) (240)
  1. "cyclophosphamide"
Formats
  1. Journal Article (1932)
  2. Review (52)
  3. Conference Paper (46)
  4. Editorial (11)
  5. Research Letter (11)
  6. Meeting Abstract (8)
  7. Correspondence (6)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)

More Groups

People
  1. Clifford Hudis (130)
  2. Larry Norton (104)
  3. Andrew Zelenetz (75)
  4. Joachim Yahalom (72)
  5. Nai-Kong Cheung (71)
  6. Richard O'Reilly (67)

More People

Years
  1. 2025 (45)
  2. 2024 (86)
  3. 2023 (56)
  4. 2022 (44)
  5. 2021 (23)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer (109)
  3. Blood (81)
  4. Leukemia and Lymphoma (50)
  5. Biology of Blood and Marrow Transplantation (49)
  6. Bone Marrow Transplantation (48)

More Publications

Publishers
  1. Elsevier Inc. (345)
  2. American Society of Clinical Oncology (163)
  3. Wiley Blackwell (150)
  4. Springer (147)
  5. American Society of Hematology (113)
  6. Lippincott Williams & Wilkins (112)

More Publishers

Results (2071)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck
    Journal Article

    Agaimy, A.; Dermawan, J. K.; Leong, I.; Stoehr, R.; Swanson, D.; Weinreb, I.; Zhang, L.; Antonescu, C. R.; Dickson, B. C.
    Genes Chromosomes and Cancer (2022)

    Fulltext@MSK | Save
  • Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
    Journal Article

    Tasian, S. K.; Silverman, L. B.; Whitlock, J. A.; Sposto, R.; Loftus, J. P.; Schafer, E. S.; Schultz, K. R.; Hutchinson, R. J.; Gaynon, P. S.; Orgel, E.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Fertility preservation in young women with breast cancer: Impact on treatment and outcomes
    Journal Article

    Crown, A.; Muhsen, S.; Sevilimedu, V.; Kelvin, J.; Goldfarb, S. B.; Gemignani, M. L.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Journal Article

    Barrios, C. H.; Saji, S.; Harbeck, N.; Zhang, H.; Jung, K. H.; Patel, S.; Patel, S.; Duc, A. N.; Liste-Hermoso, M.; Chui, S. Y.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Atezolizumab with neoadjuvant anti-human epidermal growth factor receptor 2 therapy and chemotherapy in human epidermal growth factor receptor 2-positive early breast cancer: Primary results of the randomized phase III IMpassion050 trial
    Journal Article

    Huober, J.; Barrios, C. H.; Niikura, N.; Jarząb, M.; Chang, Y. C.; Huggins-Puhalla, S. L.; Pedrini, J.; Zhukova, L.; Graupner, V.; Eiger, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: A multicenter study
    Journal Article

    Kunte, S.; Rybicki, L.; Viswabandya, A.; Tamari, R.; Bashey, A.; Keyzner, A.; Iqbal, M.; Grunwald, M. R.; Dholaria, B.; Elmariah, H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Malignancy-associated haemophagocytic lymphohistiocytosis
    Review

    Setiadi, A.; Zoref-Lorenz, A.; Lee, C. Y.; Jordan, M. B.; Chen, L. Y. C.
    The Lancet Haematology (2022)

    Fulltext@MSK | Save
  • A retrospective cohort study of treatment outcomes of adult patients with relapsed or refractory follicular lymphoma (ReCORD-FL)
    Journal Article

    Salles, G.; Schuster, S. J.; Fischer, L.; Kuruvilla, J.; Patten, P. E. M.; von Tresckow, B.; Smith, S.; Ubieto, A. J.; Davis, K. L.; Nagar, S.; more...
    HemaSphere (2022)

    Fulltext@MSK | Save
  • Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)
    Journal Article

    Leary, S. E. S.; Kilburn, L.; Geyer, J. R.; Kocak, M.; Huang, J.; Smith, K. S.; Hadley, J.; Ermoian, R.; MacDonald, T. J.; Goldman, S.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan
    Journal Article

    Moss, N. S.; Tosi, U.; Santomasso, B. D.; Beal, K.; Modi, S.
    CNS Oncology (2022)

    Fulltext@MSK | Save